Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell A Sullivan

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Biomacromolecules|December 31, 2013
Changes in glycogen structure over feeding cycle sheds new light on blood-glucose controlMitchell A Sullivan, Samuel T N Aroney, Shihan Li, et al.
The Journal of Nutritional Biochemistry|July 9, 2023
Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagyPeng Cao, Yi Wang, Cong Zhang, et al.
Cell Metabolism|July 7, 2017
Lack of Glycogenin Causes Glycogen Accumulation and Muscle Function ImpairmentGiorgia Testoni, Jordi Duran, Mar García-Rocha, et al.
EMBO Molecular Medicine|May 25, 2017
Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora diseaseFelix Nitschke, Mitchell A Sullivan, Peixiang Wang, et al.
Alcoholism, Clinical and Experimental Research|August 3, 2021
Maternal choline supplementation in a rat model of periconceptional alcohol exposure: Impacts on the fetus and placentaSarah E Steane, Arree M Fielding, Nykola L Kent, et al.
The EMBO Journal|January 13, 2025
Glycogen synthase GYS1 overactivation contributes to glycogen insolubility and malto-oligoglucan-associated neurodegenerative diseaseSilvia Nitschke, Alina P Montalbano, Megan E Whiting, et al.
Cell Reports|May 3, 2019
Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative DiseasesMitchell A Sullivan, Silvia Nitschke, Evan P Skwara, et al.
Annals of Clinical and Translational Neurology|October 9, 2020
GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body diseaseErin E Chown, Peixiang Wang, Xiaochu Zhao, et al.
Scientific Reports|September 27, 2017
Increased liver AGEs induce hepatic injury mediated through an OST48 pathwayAowen Zhuang, Felicia Yt Yap, Clinton Bruce, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 20, 2023
Reversible expansion of tissue macrophages in response to macrophage colony-stimulating factor (CSF1) transforms systemic lipid and carbohydrate metabolismSahar Keshvari, Jesse J R Masson, Michelle Ferrari-Cestari, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Biomacromolecules|December 31, 2013
Changes in glycogen structure over feeding cycle sheds new light on blood-glucose controlMitchell A Sullivan, Samuel T N Aroney, Shihan Li, et al.
The Journal of Nutritional Biochemistry|July 9, 2023
Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagyPeng Cao, Yi Wang, Cong Zhang, et al.
Cell Metabolism|July 7, 2017
Lack of Glycogenin Causes Glycogen Accumulation and Muscle Function ImpairmentGiorgia Testoni, Jordi Duran, Mar García-Rocha, et al.
EMBO Molecular Medicine|May 25, 2017
Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora diseaseFelix Nitschke, Mitchell A Sullivan, Peixiang Wang, et al.
Alcoholism, Clinical and Experimental Research|August 3, 2021
Maternal choline supplementation in a rat model of periconceptional alcohol exposure: Impacts on the fetus and placentaSarah E Steane, Arree M Fielding, Nykola L Kent, et al.
The EMBO Journal|January 13, 2025
Glycogen synthase GYS1 overactivation contributes to glycogen insolubility and malto-oligoglucan-associated neurodegenerative diseaseSilvia Nitschke, Alina P Montalbano, Megan E Whiting, et al.
Cell Reports|May 3, 2019
Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative DiseasesMitchell A Sullivan, Silvia Nitschke, Evan P Skwara, et al.
Annals of Clinical and Translational Neurology|October 9, 2020
GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body diseaseErin E Chown, Peixiang Wang, Xiaochu Zhao, et al.
Scientific Reports|September 27, 2017
Increased liver AGEs induce hepatic injury mediated through an OST48 pathwayAowen Zhuang, Felicia Yt Yap, Clinton Bruce, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 20, 2023
Reversible expansion of tissue macrophages in response to macrophage colony-stimulating factor (CSF1) transforms systemic lipid and carbohydrate metabolismSahar Keshvari, Jesse J R Masson, Michelle Ferrari-Cestari, et al.
Pageof 7